Advertisement
YOU ARE HERE: LAT HomeCollectionsSynthroid Drug
IN THE NEWS

Synthroid Drug

FEATURED ARTICLES
BUSINESS
June 2, 2001 | Reuters
The Food and Drug Administration has ruled that Abbott Laboratories Inc. must seek approval to keep selling the thyroid drug Synthroid, the No.3 most-prescribed medicine in the U.S., saying it has a "history of problems." The ruling raises the prospect that the drug, which millions of Americans take daily, could be pulled from the market, although FDA officials said they would act cautiously and analysts said such drastic action was unlikely.
ARTICLES BY DATE
BUSINESS
June 2, 2001 | Reuters
The Food and Drug Administration has ruled that Abbott Laboratories Inc. must seek approval to keep selling the thyroid drug Synthroid, the No.3 most-prescribed medicine in the U.S., saying it has a "history of problems." The ruling raises the prospect that the drug, which millions of Americans take daily, could be pulled from the market, although FDA officials said they would act cautiously and analysts said such drastic action was unlikely.
Los Angeles Times Articles
|